Consolidated Statements of Stockholders' Equity (audited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income, Net of Tax	Accumulated Deficit
Balance at Dec. 31, 2022	$ 80,754	$ 32	$ 329,387	$ 10	$ (248,675)
Balance, Shares at Dec. 31, 2022		31,827,659
Exercise of common stock options	103		103
Exercise of common stock options, Shares		57,897
Issuance of common stock and pre-funded warrants, net of issuance costs	46,518	$ 18	46,500
Issuance of common stock and pre-funded warrants, net of issuance costs, Shares		17,652,962
Issuance of common stock upon RSU vesting, shares		7,041
Shares issued under ATM, net of issuance costs	19,068	$ 6	19,062
Shares issued under ATM, net of issuance costs, Shares		6,017,568
Exercise of pre-funded warrants	2	$ 1	1
Exercise of pre-funded warrants, Shares		1,651,423
Unrealized gain on available-for-sale securities	23			23
Stock-based compensation	5,632		5,632
Net loss	(62,680)				(62,680)
Balance at Dec. 31, 2023	89,420	$ 57	400,685	33	(311,355)
Balance, Shares at Dec. 31, 2023		57,214,550
Exercise of common stock options	$ 3		3
Exercise of common stock options, Shares	1,002	1,002
Issuance of common stock and pre-funded warrants, net of issuance costs	$ 10	$ 5	5
Issuance of common stock and pre-funded warrants, net of issuance costs, Shares		5,746,376
Issuance of common stock upon RSU vesting, shares		86,574
Shares issued under ATM, net of issuance costs	4,850	$ 1	4,849
Shares issued under ATM, net of issuance costs, Shares		1,041,666
Issuance of common stock under ESPP		1,000
Exercise of common stock warrants	3,808	$ 2	3,806
Exercise of common stock warrants, Shares		1,424,272
Unrealized loss on available-for-sale securities	(33)			$ (33)
Stock-based compensation	6,971		6,971
Net loss	(93,435)				(93,435)
Balance at Dec. 31, 2024	$ 11,594	$ 65	$ 416,319		$ (404,790)
Balance, Shares at Dec. 31, 2024		65,515,440